{{Rsnum
|rsid=3813946
|Gene=CR2
|Chromosome=1
|position=207454348
|Orientation=minus
|GMAF=0.1552
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CR2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 61.7 | 36.7 | 1.7
| HCB | 85.7 | 14.3 | 0.0
| JPT | 78.0 | 22.0 | 0.0
| YRI | 82.7 | 15.4 | 1.9
| ASW | 0.0 | 0.0 | 0.0
| CHB | 85.7 | 14.3 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{omim
|id=120650
|desc=COMPLEMENT COMPONENT RECEPTOR 2; CR2
|rsnum=3813946
}}

{{omim
|id=120650
|rsnum=3813946
|variant=0001
}}

{{PMID Auto
|PMID=22673213
|Title=Transcriptional effects of a lupus-associated polymorphism in the 5' untranslated region (UTR) of human complement receptor 2 (CR2/CD21)
|OA=1
}}

{{PMID Auto
|PMID=17360460
|Title=Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus.
|OA=1
}}

{{PMID Auto
|PMID=19387458
|Title=Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing.
|OA=1
}}

{{PMID Auto
|PMID=23612877
|Title=Functional polymorphism in the 5'-UTR of CR2 is associated with susceptibility to nasopharyngeal carcinoma
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}